Management of prostate cancer: future treatment approaches

Prostate cancer is now the most commonly diagnosed cancer in men. This may reflect a true increase in the incidence of the disease, but a component of it is certainly related to increased detection rates due to opportunistic prostate specific antigen (PSA) testing. In this article, Professor Malcolm Mason reviews the current treatment of prostate cancer and considers promising future treatment options, including the possibility of prevention as suggested by recent studies. Copyright © 2009 John Wiley & Sons, Ltd.